These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6945292)

  • 21. Surface antigens in acute myeloblastic leukaemia: a study using heterologous antisera.
    Tupchong L; MacLennan IC
    Br J Cancer; 1978 Oct; 38(4):481-95. PubMed ID: 281967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of MTG8-specific cytotoxic T-cell lines: MTG8 is probably a tumour antigen that is recognized by cytotoxic T cells in AML1-MTG8-fused gene-positive acute myelogenous leukaemia.
    Maeda M; Otsuka T; Kimura N; Kozu T; Fukuyama T; Uchida N; Sugio Y; Itoh Y; Iino T; Inaba S; Niho Y
    Br J Haematol; 2000 Nov; 111(2):570-9. PubMed ID: 11122105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological detection of B-cell ("Ia-like") antigens in serum of normal donor and in some sera of leukaemic patients.
    Koubek K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):408-15. PubMed ID: 6182060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon.
    Leung DY; Collins T; Lapierre LA; Geha RS; Pober JS
    J Clin Invest; 1986 May; 77(5):1428-35. PubMed ID: 3084559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4(+)and CD8(+)T-cell reactions against leukemia-associated- or minor-histocompatibility-antigens in AML-patients after allogeneic SCT.
    Steger B; Milosevic S; Doessinger G; Reuther S; Liepert A; Braeu M; Schick J; Vogt V; Schuster F; Kroell T; Busch DH; Borkhardt A; Kolb HJ; Tischer J; Buhmann R; Schmetzer H
    Immunobiology; 2014 Apr; 219(4):247-60. PubMed ID: 24315637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement-dependent cytotoxicity induced by therapeutic antibodies in B-cell acute lymphoblastic leukemia is dictated by target antigen expression levels and augmented by loss of membrane-bound complement inhibitors.
    Loeff FC; van Egmond HME; Nijmeijer BA; Falkenburg JHF; Halkes CJ; Jedema I
    Leuk Lymphoma; 2017 Sep; 58(9):1-14. PubMed ID: 28140725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical relevance of circulating immune complexes in human leukemia. Association in acute leukemia of the presence of immune complexes with unfavorable prognosis.
    Carpentier NA; Lange GT; Fiere DM; Fournie GJ; Lambert PH; Miescher PA
    J Clin Invest; 1977 Oct; 60(4):874-84. PubMed ID: 268330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
    Ball ED; Graziano RF; Fanger MW
    J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human leukemia-associated anti-nuclear reactivity.
    Klein G; Steiner M; Wiener F; Klein E
    Proc Natl Acad Sci U S A; 1974 Mar; 71(3):685-9. PubMed ID: 4595570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of blood group-like antigens on the T lymphocytes of acute leukaemia patients in remission.
    Pullen S; Hersey P
    Clin Exp Immunol; 1980 Feb; 39(2):403-10. PubMed ID: 6966993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immune complexes in the serum of patients with acute myeloblastic leukemia].
    Späth P; Berchtold P; Engler H; Bütler R
    Schweiz Med Wochenschr; 1984 Oct; 114(40):1373-5. PubMed ID: 6593823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-mediated immune responses between HLA-identical siblings: recognition of antigenic changes associated with acute myelogenous leukaemia.
    Zier KS; Huber C; Albert E; Braunsteiner H
    Clin Exp Immunol; 1980 Apr; 40(1):136-46. PubMed ID: 6446429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytotoxic antibodies to leukemia cells in normal human sera].
    Dorè JF; Bertoglio J; Guibout C
    Ann Immunol (Paris); 1977; 128(1-2):155-7. PubMed ID: 265695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous immune complex nephropathy associated with malignancy I. Studies on the nature and immunopathogenic significance of glomerular bound antigen and antibody, isolation and characterization of tumor specific antigen and antibody and circulating immune complexes.
    Ozawa T; Pluss R; Lacher J; Boedecker E; Guggenheim S; Hammond W; McIntosh R
    Q J Med; 1975 Oct; 44(176):523-41. PubMed ID: 53850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological identification of immunogenic antigens in acute monocytic leukemia.
    Chen G; Zhang W; Cao X; Li F; Liu X; Yao L
    Leuk Res; 2005 May; 29(5):503-9. PubMed ID: 15755502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia.
    Griggio V; Mandili G; Vitale C; Capello M; Macor P; Serra S; Castella B; Peola S; Foglietta M; Drandi D; Omedé P; Sblattero D; Cappello P; Chiarle R; Deaglio S; Boccadoro M; Novelli F; Massaia M; Coscia M
    Oncotarget; 2017 Jan; 8(2):3274-3288. PubMed ID: 27906678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibodies to novel myeloid antigens reveal human neutrophil heterogeneity.
    Ball ED; Graziano RF; Shen L; Fanger MW
    Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5374-8. PubMed ID: 6752945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of a tumor-associated antigen on the surface of human myelogenous leukemia cells.
    Malcolm AJ; Shipman RC; Levy JG
    J Immunol; 1982 Jun; 128(6):2599-603. PubMed ID: 7042842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vim-2, candidate monoclonal antibody for purging autologous marrow grafts in acute myeloblastic leukaemia.
    Delwel R; Bot F; Knapp W; Löwenberg B
    Bone Marrow Transplant; 1987 Aug; 2(2):149-54. PubMed ID: 3332163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of complement-fixing antibodies against antigens of Gross virus-induced rat lymphoma and normal rat thymus in sera of patients with some forms of malignancies.
    Simkovic D; Chorváth B; Hlubinová K; Valentová N; Stevonková J; Babusíková O; Simkovicová M
    Neoplasma; 1977; 24(4):357-63. PubMed ID: 269322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.